Chemotherapy Rechallenge or Reintroduction Compared to Regorafenib or Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: A Propensity Score Analysis of Treatment Beyond Second Line (Proserpyna Study)
Titel:
Chemotherapy Rechallenge or Reintroduction Compared to Regorafenib or Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: A Propensity Score Analysis of Treatment Beyond Second Line (Proserpyna Study)
Auteur:
Calegari, M.A. Zurlo, I.V. Dell'Aquila, E. Basso, M. Orlandi, A. Bensi, M. Camarda, F. Anghelone, A. Pozzo, C. Sperduti, I. Salvatore, L. Santini, D. Corsi, D.C. Bria, E. Tortora, G.